Jennison Associates’s Cardlytics CDLX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-50,474
| Closed | -$474K | – | 582 |
|
|
2022
Q3 | $474K | Sell |
50,474
-686,828
| -93% | -$6.45M | ﹤0.01% | 586 |
|
|
2022
Q2 | $16.4M | Buy |
737,302
+145,544
| +25% | +$3.25M | 0.02% | 331 |
|
|
2022
Q1 | $32.5M | Buy |
591,758
+21,834
| +4% | +$1.2M | 0.02% | 285 |
|
|
2021
Q4 | $37.7M | Buy |
569,924
+376,539
| +195% | +$24.9M | 0.02% | 271 |
|
|
2021
Q3 | $16.2M | Sell |
193,385
-118,965
| -38% | -$9.99M | 0.01% | 395 |
|
|
2021
Q2 | $39.6M | Sell |
312,350
-1,321
| -0.4% | -$168K | 0.03% | 261 |
|
|
2021
Q1 | $34.4M | Sell |
313,671
-3,650
| -1% | -$400K | 0.03% | 274 |
|
|
2020
Q4 | $45.3M | Sell |
317,321
-281,090
| -47% | -$40.1M | 0.03% | 221 |
|
|
2020
Q3 | $42.2M | Buy |
598,411
+159,591
| +36% | +$11.3M | 0.03% | 213 |
|
|
2020
Q2 | $30.7M | Sell |
438,820
-4,968
| -1% | -$348K | 0.03% | 235 |
|
|
2020
Q1 | $15.5M | Sell |
443,788
-38,502
| -8% | -$1.35M | 0.02% | 284 |
|
|
2019
Q4 | $30.3M | Sell |
482,290
-220,431
| -31% | -$13.9M | 0.03% | 254 |
|
|
2019
Q3 | $23.6M | Sell |
702,721
-478,948
| -41% | -$16.1M | 0.02% | 294 |
|
|
2019
Q2 | $30.7M | Sell |
1,181,669
-68,235
| -5% | -$1.77M | 0.03% | 282 |
|
|
2019
Q1 | $20.7M | Sell |
1,249,904
-14,450
| -1% | -$239K | 0.02% | 350 |
|
|
2018
Q4 | $13.7M | Buy |
1,264,354
+465,855
| +58% | +$5.05M | 0.02% | 401 |
|
|
2018
Q3 | $20M | Sell |
798,499
-7,782
| -1% | -$195K | 0.02% | 399 |
|
|
2018
Q2 | $17.5M | Sell |
806,281
-5,004
| -0.6% | -$109K | 0.02% | 415 |
|
|
2018
Q1 | $11.9M | Buy |
+811,285
| New | +$11.9M | 0.01% | 443 |
|